Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | PRNP | P04156 | 1/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.40 |
| ▸ | RELA | Q04206 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 4/20 | 0.39 |
| ▸ | BCHE | P06276 | 3/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 3/20 | 0.38 |
| ▸ | POLB | P06746 | 3/20 | 0.38 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.38 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.38 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.38 |
| ▸ | CDK5R1 | Q15078 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9406874 | 0.76 | PRNP (0.45) | NPC1PRNPRXFP1KDM4EMAPT | |
| SCHEMBL9406832 | 0.72 | NPC1 (0.56) | NPC1KDM4EMAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL29706044 | 0.72 | ACHE (0.54) | KDM4EMAPTSMN1; SMN2ALDH1A1ACHE | |
| SCHEMBL3792562 | 0.71 | PRNP (0.42) | NPC1PRNPRXFP1KDM4EMAPT | |
| SCHEMBL9406790 | 0.71 | NPC1 (0.74) | NPC1KDM4EMAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL9455514 | 0.69 | KDM4E (0.52) | NPC1KDM4EMAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL15886676 | 0.67 | PRNP (0.52) | NPC1PRNPRXFP1KDM4EMAPT | |
| SCHEMBL23195662 | 0.66 | NPC1 (0.48) | NPC1PRNPRXFP1KDM4EMAPT | |
| SCHEMBL441572 | 0.66 | NFKBIA (0.52) | KDM4EMAPTSMN1; SMN2ALDH1A1RAB9A | |
| SCHEMBL3294700 | 0.65 | KDM4E (0.47) | NPC1PRNPRXFP1KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0328535-B1 | THE ADMINISTRATION OF MONOAMINE ACRIDINES IN CHOLINERGIC NEURONAL DEFICIT STATES | SUMMERS WILLIAM KOOPMANS (US) | 1994-06-01 | — | — | EP | disclosed |
| EP-0595365-A1 | Pharmaceutical composition for the treatment of underlying nonpharmacologically induced nervous system cholinergic deficit state comprising monoamine acridine derivatives | Summers, William Koopmans (US) | 1994-05-04 | — | — | EP | disclosed |
| EP-0328535-A4 | THE ADMINISTRATION OF MONOAMINE ACRIDINES IN CHOLINERGIC NEURONAL DEFICIT STATES | — | 1991-05-22 | — | — | EP | disclosed |
| EP-0328535-A1 | THE ADMINISTRATION OF MONOAMINE ACRIDINES IN CHOLINERGIC NEURONAL DEFICIT STATES. | SUMMERS WILLIAM KOOPMANS | 1989-08-23 | — | — | EP | disclosed |
| US-4816456-A | Administration of monoamine acridines in cholinergic neuronal deficit states | SUMMERS WILLIAM K (US) | 1989-03-28 | — | — | US | disclosed |
| WO-1988002256-A1 | THE ADMINISTRATION OF MONOAMINE ACRIDINES IN CHOLINERGIC NEURONAL DEFICIT STATES | SUMMERS WILLIAM KOOPMANS (US) | 1988-04-07 | — | — | WO | disclosed |